{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:42:26Z","timestamp":1793832146356,"version":"4.6.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Spinal Cord"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Study design<\/jats:title>\n                    <jats:p>Investigator-initiated, single-arm, first-in-human pilot study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To evaluate the safety and feasibility of intramedullary administration of polymerized laminin in individuals with acute complete spinal cord injury (SCI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Public and private hospitals in Brazil.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Eight patients with acute traumatic SCI classified as AIS A (C4\u2013T12) were enrolled within days after injury (mean 2.3 days). Polymerized laminin was administered as a single intramedullary dose (1\u2009\u00b5g\/kg; total 55\u201380\u2009\u00b5g). Patients were followed for 12 months using standardized neurological, laboratory, and neurophysiological assessments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Intramedullary administration was uneventful in all cases. No neurological deterioration or serious adverse events attributable to the intervention were observed. Mild laboratory abnormalities were transient and not associated with hepatic or renal toxicity. Three participants died during follow-up. Deaths were reviewed by the Brazilian National Research Ethics Commission (CONEP) and an external clinical consultant, and were not considered related to the intervention. Neurological improvement of at least two AIS grades was observed in six participants, including one who died after progressing to AIS C. Improvements in motor and\/or somatosensory evoked potentials were observed in three patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Intramedullary administration of polymerized laminin was uneventful and appeared to be safe in this small and heterogeneous cohort. Although the study design does not allow conclusions regarding efficacy, it provides proof-of-concept for this therapeutic approach and justifies further evaluation in controlled clinical studies. The study was initiated in December 2016, prior to current requirements for prospective trial registration.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41393-026-01238-6","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:47:30Z","timestamp":1785851250000},"page":"834-844","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Intramedullary injection of polymerized laminin in acute traumatic spinal cord injury: a first-in-human pilot study"],"prefix":"10.1038","volume":"64","author":[{"given":"Marco Aurelio B.","family":"Lima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla","family":"Menezes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise R.","family":"Xerez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7970-514X","authenticated-orcid":false,"given":"Bruno A.","family":"C\u00f4rtes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o R. L.","family":"Menezes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo S.","family":"Holanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana D.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6891-9529","authenticated-orcid":false,"given":"Eliel S.","family":"Leite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4264-6048","authenticated-orcid":false,"given":"Olavo B.","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Aur\u00e9lio A. M. de","family":"Faria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2735-287X","authenticated-orcid":false,"given":"Arthur de Freitas","family":"Forte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5704-8571","authenticated-orcid":false,"given":"Livia V.","family":"Abreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5221-4241","authenticated-orcid":false,"given":"Renata C. L.","family":"Lichtenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00edntia F.","family":"Santana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurilio","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lio V.","family":"Gra\u00e7a-Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro U. C.","family":"Jorge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Cristina","family":"Franzoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7014-2002","authenticated-orcid":false,"given":"Arthur S.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose M.","family":"Frajtag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3020-9580","authenticated-orcid":false,"given":"Tatiana","family":"Coelho\u2010Sampaio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"key":"1238_CR1","doi-asserted-by":"crossref","unstructured":"Ahuja CS, Nori S, Tetreault L, Wilson J, Kwon B, Harrop J, et al. Traumatic spinal cord injury-repair and regeneration. Neurosurgery. 2017;80:S9\u2013S22.","DOI":"10.1093\/neuros\/nyw080"},{"key":"1238_CR2","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201911505","volume":"12","author":"M Griffin","year":"2020","unstructured":"Griffin M, Bradke F. Therapeutic repair for spinal cord injury: combinatory approaches to address a multifaceted problem. EMBO Mol Med. 2020;12:e11505.","journal-title":"EMBO Mol Med"},{"key":"1238_CR3","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1089\/neu.2020.7473","volume":"38","author":"S Kirshblum","year":"2021","unstructured":"Kirshblum S, Snider B, Eren F, Guest J. Characterizing natural recovery after traumatic spinal cord injury. J Neurotrauma. 2021;38:1267\u201384.","journal-title":"J Neurotrauma"},{"key":"1238_CR4","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/s41393-019-0299-8","volume":"57","author":"AA Aimetti","year":"2019","unstructured":"Aimetti AA, Kirshblum S, Curt A, Mobley J, Grossman RG, Guest JD. Natural history of neurological improvement following complete (AIS A) thoracic spinal cord injury across three registries to guide acute clinical trial design and interpretation. Spinal Cord. 2019;57:753\u201362.","journal-title":"Spinal Cord"},{"key":"1238_CR5","doi-asserted-by":"publisher","first-page":"683","DOI":"10.3171\/2018.10.SPINE18802","volume":"30","author":"M Khorasanizadeh","year":"2019","unstructured":"Khorasanizadeh M, Yousefifard M, Eskian M, Lu Y, Chalangari M, Harrop JS, et al. Neurological recovery following traumatic spinal cord injury: a systematic review and meta-analysis. J Neurosurg Spine. 2019;30:683\u201399.","journal-title":"J Neurosurg Spine"},{"key":"1238_CR6","doi-asserted-by":"publisher","first-page":"a005108","DOI":"10.1101\/cshperspect.a005108","volume":"3","author":"CS Barros","year":"2011","unstructured":"Barros CS, Franco SJ, M\u00fcller U. Extracellular matrix: functions in the nervous system. Cold Spring Harb Perspect Biol. 2011;3:a005108.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"1238_CR7","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1146\/annurev.cellbio.20.010403.094555","volume":"20","author":"JH Miner","year":"2004","unstructured":"Miner JH, Yurchenco PD. Laminin functions in tissue morphogenesis. Annu Rev Cell Dev Biol. 2004;20:255\u201384.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"1238_CR8","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.ydbio.2008.12.006","volume":"327","author":"ZL Chen","year":"2009","unstructured":"Chen ZL, Haegeli V, Yu H, Strickland S. Cortical deficiency of laminin gamma1 impairs the AKT\/GSK-3\u03b2 signaling pathway and leads to defects in neurite outgrowth and neuronal migration. Dev Biol. 2009;327:158\u201368.","journal-title":"Dev Biol"},{"key":"1238_CR9","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1002\/glia.24117","volume":"70","author":"M Kang","year":"2022","unstructured":"Kang M, Yao Y. Laminin regulates oligodendrocyte development and myelination. Glia. 2022;70:414\u201329.","journal-title":"Glia"},{"key":"1238_CR10","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1002\/j.1460-2075.1985.tb03755.x","volume":"4","author":"P Liesi","year":"1985","unstructured":"Liesi P. Do neurons in the vertebrate CNS migrate on laminin? EMBO J. 1985;4:1163\u201370.","journal-title":"EMBO J"},{"key":"1238_CR11","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1083\/jcb.200307068","volume":"163","author":"ZL Chen","year":"2003","unstructured":"Chen ZL, Strickland S. Laminin gamma1 is critical for Schwann cell differentiation, axon myelination, and regeneration in the peripheral nerve. J Cell Biol. 2003;163:889\u201399.","journal-title":"J Cell Biol"},{"key":"1238_CR12","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.1523\/JNEUROSCI.22-08-03144.2002","volume":"22","author":"B Grimpe","year":"2002","unstructured":"Grimpe B, Dong S, Doller C, Temple K, Malouf AT, Silver J. The critical role of basement membrane-independent laminin gamma 1 chain during axon regeneration in the CNS. J Neurosci. 2002;22:3144\u201360.","journal-title":"J Neurosci"},{"key":"1238_CR13","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41586-018-0467-6","volume":"561","author":"MA Anderson","year":"2018","unstructured":"Anderson MA, O\u2019Shea TM, Burda JE, Ao Y, Barlatey SL, Bernstein AM, et al. Required growth facilitators propel axon regeneration across complete spinal cord injury. Nature. 2018;561:396\u2013400.","journal-title":"Nature"},{"key":"1238_CR14","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aal4165","volume":"10","author":"D Zhang","year":"2017","unstructured":"Zhang D, Yang S, Toledo EM, Gyllborg D, Salt\u00f3 C, Villaescusa JC, et al. Niche-derived laminin-511 promotes midbrain dopaminergic neuron survival and differentiation through YAP. Sci Signal. 2017;10:eaa14165.","journal-title":"Sci Signal"},{"key":"1238_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2020.105823","volume":"127","author":"R Hallmann","year":"2020","unstructured":"Hallmann R, Hannocks MJ, Song J, Zhang X, Di Russo J, Luik AL, et al. The role of basement membrane laminins in vascular function. Int J Biochem Cell Biol. 2020;127:105823.","journal-title":"Int J Biochem Cell Biol"},{"key":"1238_CR16","doi-asserted-by":"publisher","first-page":"3880","DOI":"10.1523\/JNEUROSCI.3064-17.2018","volume":"38","author":"MA Nascimento","year":"2018","unstructured":"Nascimento MA, Sorokin LM, Coelho-Sampaio T. Fractone bulbs derive from ependymal cells and their laminin composition influence the stem cell niche in the subventricular zone. J Neurosci. 2018;38:3880\u20139.","journal-title":"J Neurosci"},{"key":"1238_CR17","doi-asserted-by":"publisher","first-page":"11714","DOI":"10.1074\/jbc.M709301200","volume":"283","author":"MM Barroso","year":"2008","unstructured":"Barroso MM, Freire E, Limaverde GSC, Rocha GM, Batista EJO, Weissm\u00fcller G, et al. Artificial laminin polymers assembled in acidic pH mimic basement membrane organization. J Biol Chem. 2008;283:11714\u201320.","journal-title":"J Biol Chem"},{"key":"1238_CR18","doi-asserted-by":"publisher","first-page":"4867","DOI":"10.1242\/jcs.00173","volume":"115","author":"E Freire","year":"2002","unstructured":"Freire E, Gomes FCA, Linden R, Moura Neto V, Coelho-Sampaio T. Structure of laminin substrate modulates cellular signaling for neuritogenesis. J Cell Sci. 2002;115:4867\u201376.","journal-title":"J Cell Sci"},{"key":"1238_CR19","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/jnr.23298","volume":"92","author":"C Hochmann-Mendez","year":"2014","unstructured":"Hochmann-Mendez C, Menezes JRL, Sholl-Franco A, Coelho-Sampaio T. Polylaminin recognition by retinal cells. J Neurosci Res. 2014;92:24\u201334.","journal-title":"J Neurosci Res"},{"key":"1238_CR20","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1002\/jbm.a.36429","volume":"106","author":"AE Haggerty","year":"2018","unstructured":"Haggerty AE, Al-Ali H, Oudega M. Soluble laminin polymers enhance axon growth of primary neurons in vitro. J Biomed Mater Res A. 2018;106:2372\u201381.","journal-title":"J Biomed Mater Res A"},{"key":"1238_CR21","doi-asserted-by":"publisher","first-page":"4513","DOI":"10.1096\/fj.10-157628","volume":"24","author":"K Menezes","year":"2010","unstructured":"Menezes K, Menezes JRL, Nascimento MA, Santos RS, Coelho-Sampaio T. Polylaminin, a polymeric form of laminin, promotes regeneration after spinal cord injury. FASEB J. 2010;24:4513\u201322.","journal-title":"FASEB J"},{"key":"1238_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2025.1592687","volume":"12","author":"CM Chize","year":"2025","unstructured":"Chize CM, Vivas DG, Menezes K, Freire M, Jiddu RFP, Gra\u00e7a-Souza AV, et al. A laminin-based therapy for dogs with chronic spinal cord injury: promising results of a longitudinal trial. Front Vet Sci. 2025;12:1592687.","journal-title":"Front Vet Sci"},{"key":"1238_CR23","doi-asserted-by":"publisher","first-page":"e109388","DOI":"10.1371\/journal.pone.0109388","volume":"9","author":"C Hochmann-Mendez","year":"2014","unstructured":"Hochmann-Mendez C, Cantini M, Moratal D, Salmeron-Sanchez M, Coelho-Sampaio T. A fractal nature for polymerized laminin. PLoS One. 2014;9:e109388.","journal-title":"PLoS One"},{"key":"1238_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.46292\/sci2702-1","volume":"27","author":"F Rupp","year":"2021","unstructured":"Rupp F, Biering-S\u00f8rensen F, Burns SP, Graves DE, Guest J, Jones L, et al. International standards for neurological classification of spinal cord injury: Revised 2019. Top Spinal Cord Inj Rehabil. 2021;27:1\u201322.","journal-title":"Top Spinal Cord Inj Rehabil"},{"key":"1238_CR25","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/sj.sc.3101603","volume":"42","author":"JF Ditunno","year":"2004","unstructured":"Ditunno JF, Little JW, Tessler A, Burns AS. Spinal shock revisited: a four-phase model. Spinal Cord. 2004;42:383\u201395.","journal-title":"Spinal Cord"},{"key":"1238_CR26","volume-title":"Guidance for Industry: Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers","author":"FDA","year":"2005","unstructured":"FDA. Guidance for Industry: Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers. Rockville, MD, USA: FDA; 2005."},{"key":"1238_CR27","volume-title":"Guidance for Industry, Investigators, and Reviewers: Exploratory IND Studies","author":"FDA","year":"2006","unstructured":"FDA. Guidance for Industry, Investigators, and Reviewers: Exploratory IND Studies. Rockville, MD: Food and Drug Administration; 2006."},{"key":"1238_CR28","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/s41573-020-0080-x","volume":"19","author":"T Burt","year":"2020","unstructured":"Burt T, Young G, Lee W, Kusuhara H, Langer O, Rowland M, et al. Phase 0\/microdosing approaches: time for mainstream application in drug development? Nat Rev Drug Discov. 2020;19:801\u201318.","journal-title":"Nat Rev Drug Discov"},{"key":"1238_CR29","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3171\/2012.5.AOSPINE12127","volume":"17","author":"RG Grossman","year":"2012","unstructured":"Grossman RG, Frankowski RF, Burau KD, Toups EG, Crommett JW, Johnson MM, et al. Incidence and severity of acute complications after spinal cord injury. J Neurosurg Spine. 2012;17:119\u201328.","journal-title":"J Neurosurg Spine"},{"key":"1238_CR30","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.brainresbull.2008.06.002","volume":"78","author":"G Scivoletto","year":"2009","unstructured":"Scivoletto G, Di Donna V. Prediction of walking recovery after spinal cord injury. Brain Res Bull. 2009;78:43\u201351.","journal-title":"Brain Res Bull"},{"key":"1238_CR31","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1097\/00007632-200112151-00006","volume":"26","author":"PA Ball","year":"2001","unstructured":"Ball PA. Critical care of spinal cord injury. Spine. 2001;26:S27\u2013S30.","journal-title":"Spine"},{"key":"1238_CR32","doi-asserted-by":"publisher","first-page":"e854","DOI":"10.1097\/CCM.0000000000003937","volume":"47","author":"F Jiang","year":"2019","unstructured":"Jiang F, Jaja BNR, Kurpad SN, Badhiwala JH, Aarabi B, Grossman RG, et al. Acute adverse events after spinal cord injury and their relationship to long-term neurologic and functional outcomes: analysis from the North American clinical trials network for spinal cord injury. Crit Care Med. 2019;47:e854\u2013e862.","journal-title":"Crit Care Med"},{"key":"1238_CR33","doi-asserted-by":"publisher","first-page":"e003","DOI":"10.1097\/OI9.0000000000000003","volume":"1","author":"T Higashi","year":"2018","unstructured":"Higashi T, Eguchi H, Wakayama Y, Sumi M, Saito T. Risk factors associated with mortality after traumatic cervical spinal cord injury. OTA Int. 2018;1:e003.","journal-title":"OTA Int"},{"key":"1238_CR34","first-page":"67","volume":"67","author":"CR Neumann","year":"2009","unstructured":"Neumann CR, Brasil AV, Albers F. Risk factors for mortality in traumatic cervical spinal cord injury: Brazilian data. J Trauma. 2009;67:67\u201370.","journal-title":"J Trauma"},{"key":"1238_CR35","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1590\/S1414-81452012000400015","volume":"16","author":"TSC Santos","year":"2012","unstructured":"Santos TSC, Guimar\u00e3es RM, Boeira SF. Spinal cord injury epidemiology in public emergency rooms in the municipality of rio de janeiro. Esc Anna Nery. 2012;16:747\u201353.","journal-title":"Esc Anna Nery"},{"key":"1238_CR36","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1089\/089771503765355540","volume":"20","author":"AS Burns","year":"2003","unstructured":"Burns AS, Lee BS, Ditunno JF Jr, Tessler A. Patient selection for clinical trials: the reliability of the early spinal cord injury examination. J Neurotrauma. 2003;20:477\u201382.","journal-title":"J Neurotrauma"},{"key":"1238_CR37","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3389\/fnhum.2014.00141","volume":"8","author":"G Scivoletto","year":"2014","unstructured":"Scivoletto G, Tamburella F, Laurenza L, Torre M, Molinari M. Who is going to walk? A review of the factors influencing walking recovery after spinal cord injury. Front Hum Neurosci. 2014;8:141.","journal-title":"Front Hum Neurosci"},{"key":"1238_CR38","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/s41393-025-01114-9","volume":"63","author":"A Khavandegar","year":"2025","unstructured":"Khavandegar A, Dehnavi NS, Ganau M, Ramezani Z, Khodadoust E, Tabatabaei MSHZ, et al. Neuroregenerative and neuroprotective effects of bioengineered scaffolds in spinal cord injury: a systematic review of preclinical and early phase clinical studies. Spinal Cord. 2025;63:451\u201369.","journal-title":"Spinal Cord"},{"key":"1238_CR39","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1002\/dneu.20931","volume":"71","author":"MyersJP Santiago-Medina","year":"2011","unstructured":"Santiago-Medina MyersJP, Gomez M. TM. Regulation of axonal pathfinding by integrin-ECM interactions. Dev Neurobiol. 2011;71:901\u201323.","journal-title":"Dev Neurobiol"},{"key":"1238_CR40","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1126\/science.abh3602","volume":"274","author":"Z \u00c1lvarez","year":"2021","unstructured":"\u00c1lvarez Z, Kolberg-Edelbrock AN, Sasselli IR, Ortega JE, Qiu R, Syrgiannis Z, et al. Bioactive scaffolds with enhanced supramolecular motion promote recovery from spinal cord injury. Science. 2021;274:848\u201356.","journal-title":"Science"},{"key":"1238_CR41","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1179\/2045772312Y.0000000069","volume":"37","author":"SM Amr","year":"2014","unstructured":"Amr SM, Gouda A, Koptan WT, Galal AA, Abdel-Fattah DS, Rashed LA, et al. Bridging defects in chronic spinal cord injury using peripheral nerve grafts combined with a chitosan-laminin scaffold and enhancing regeneration through them by co-transplantation with bone-marrow-derived mesenchymal stem cells: case series of 14 patients. J Spinal Cord Med. 2014;37:54\u201371.","journal-title":"J Spinal Cord Med"},{"key":"1238_CR42","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/0896-6273(95)90285-6","volume":"14","author":"TB Kuhn","year":"1995","unstructured":"Kuhn TB, Schmidt MF, Kater SB. Laminin and fibronectin guideposts signal sustained but opposite effects to passing growth cones. Neuron. 1995;14:275\u201385.","journal-title":"Neuron"},{"key":"1238_CR43","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1038\/nn.2401","volume":"12","author":"G Courtine","year":"2009","unstructured":"Courtine G, Gerasimenko Y, van den Brand R, Yew A, Musienko P, Zhong H, et al. Transformation of nonfunctional spinal circuits into functional states after the loss of brain input. Nat Neurosci. 2009;12:1333\u201342.","journal-title":"Nat Neurosci"},{"key":"1238_CR44","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1523\/JNEUROSCI.3960-04.2005","volume":"25","author":"MA Oatway","year":"2005","unstructured":"Oatway MA, Chen Y, Bruce JC, Dekaban GA, Weaver LC. Anti-CD11d integrin antibody treatment restores normal serotonergic projections to the dorsal, intermediate, and ventral horns of the injured spinal cord. J Neurosci. 2005;25:637\u201347.","journal-title":"J Neurosci"},{"key":"1238_CR45","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.jphysparis.2007.05.003","volume":"100","author":"M Falgairolle","year":"2006","unstructured":"Falgairolle M, de Seze M, Juvin L, Morin D, Cazalets JR. Coordinated network functioning in the spinal cord: an evolutionary perspective. J Physiol Paris. 2006;100:304\u201316.","journal-title":"J Physiol Paris"},{"key":"1238_CR46","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/s41591-021-01663-5","volume":"28","author":"A Rowald","year":"2022","unstructured":"Rowald A, Komi S, Demesmaeker R, Baaklini E, Hernandez-Charpak SD, Paoles E, et al. Activity-dependent spinal cord neuromodulation rapidly restores trunk and leg motor functions after complete paralysis. Nat Med. 2022;28:260\u201371.","journal-title":"Nat Med"},{"key":"1238_CR47","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/sc.2009.198","volume":"48","author":"JF Ditunno","year":"2010","unstructured":"Ditunno JF. Outcome measures: evolution in clinical trials of neurological\/functional recovery in spinal cord injury. Spinal Cord. 2010;48:674\u201384.","journal-title":"Spinal Cord"}],"container-title":["Spinal Cord"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41393-026-01238-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41393-026-01238-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41393-026-01238-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:10:02Z","timestamp":1793722202000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41393-026-01238-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":47,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1238"],"URL":"https:\/\/doi.org\/10.1038\/s41393-026-01238-6","relation":{},"ISSN":["1362-4393","1476-5624"],"issn-type":[{"value":"1362-4393","type":"print"},{"value":"1476-5624","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]},"assertion":[{"value":"8 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"T.C.-S. reports a consulting relationship with Laborat\u00f3rio Crist\u00e1lia, initiated during the course of the study (after study initiation and prior to its completion). This relationship had no role in the study design, data collection, data analysis, data interpretation, or preparation of the manuscript. The remaining authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The study protocol was reviewed and approved by the Brazilian National Commission for Ethics in Research (CONEP; CAAE 3.474.884). The study was initiated in December 2016, prior to current requirements for prospective clinical trial registration, and retrospectively registered at the Brazilian Clinical Trials Registry (ReBEC), which is part of the World Health Organization International Clinical Trials Registry Platform (ICTRP-WHO). The ReBEC identifier code is RBR-9dfvgp, and the trial received the Universal Trial Number (UTN) U1111-1144-5390. Written informed consent was obtained from all participants after the nature and possible consequences of the study had been explained.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All participants provided written informed consent for publication of anonymized data. No identifying information is disclosed, and all images were processed, including blurring where appropriate, to ensure participant confidentiality.","order":3,"name":"Ethics","label":"Patient consent for images or information used in a manuscript","group":{"name":"EthicsHeading","label":"Ethics"}}]}}